Rapid Micro Biosystems (NASDAQ:RPID) Announces Earnings Results, Misses Expectations By $0.01 EPS

Key Points

• Rapid Micro Biosystems reported a quarterly loss of ($0.27) EPS, missing expectations by $0.01, while revenue was slightly above estimates at $7.26 million.
• Shares of Rapid Micro Biosystems fell by $0.58, closing at $2.68, and the stock has a market capitalization of $117.42 million.
• Lake Street Capital initiated coverage with a "buy" rating and a price target of $8.00 for the stock.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.01), Zacks reports. The company had revenue of $7.26 million for the quarter, compared to the consensus estimate of $7.10 million. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Performance

NASDAQ RPID traded down $0.58 on Tuesday, hitting $2.68. The stock had a trading volume of 354,823 shares, compared to its average volume of 285,471. The firm has a 50-day moving average of $3.52 and a 200-day moving average of $2.95. The company has a market capitalization of $117.42 million, a price-to-earnings ratio of -2.58 and a beta of 1.32. Rapid Micro Biosystems has a 52-week low of $0.80 and a 52-week high of $4.50.

Insider Activity

In related news, CEO Robert G. Jr. Spignesi sold 11,881 shares of the firm's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $3.32, for a total value of $39,444.92. Following the sale, the chief executive officer directly owned 970,550 shares of the company's stock, valued at $3,222,226. This trade represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold a total of 57,443 shares of company stock valued at $195,952 in the last quarter. Company insiders own 29.96% of the company's stock.

Institutional Investors Weigh In On Rapid Micro Biosystems

A hedge fund recently raised its stake in Rapid Micro Biosystems stock. Geode Capital Management LLC grew its stake in shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Free Report) by 1.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 204,079 shares of the company's stock after buying an additional 3,143 shares during the quarter. Geode Capital Management LLC owned 0.47% of Rapid Micro Biosystems worth $704,000 at the end of the most recent quarter. 52.60% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Lake Street Capital started coverage on Rapid Micro Biosystems in a research report on Monday, July 28th. They set a "buy" rating and a $8.00 price target on the stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.